Latest Articles
Correction Open Access

Correction: Do We Really Need to Continue Pharmacotherapy for Opioid Use Disorder (OUD) Indefinitely?
Rajendra D. Badgaiyan, Sampada Sinha and Kenneth Blum
Published on: June 30, 2015
doi: 10.17756/jrds.2015-013
Citation: Badgaiyan RD, Sinha S, Blum K. 2015. Correction: Do We Really Need to Continue Pharmacotherapy for Opioid Use Disorder (OUD) Indefinitely? J Reward Defic Syndr 1(2): 81.
HTML (View Full text) | PDF (Download Full text)
Short Commentary Open Access

Coupling Neurogenetics (GARS™) and a Nutrigenomic Based Dopaminergic Agonist to Treat Reward Deficiency Syndrome (RDS): Targeting Polymorphic Reward Genes for Carbohydrate Addiction Algorithms
Kenneth Blum, Thomas Simpatico, Rajendra D. Badgaiyan, Zsolt Demetrovics, James Fratantonio, Gozde Agan, Marcelo Febo and Mark S. Gold
Published on: June 24, 2015
doi: 10.17756/jrds.2015-012
Citation: Blum K, Simpatico T, Badgaiyan RD, Demetrovics Z, Fratantonio J, et al. 2015. Coupling Neurogenetics (GARS™) and a Nutrigenomic Based Dopaminergic Agonist to Treat Reward Deficiency Syndrome (RDS): Targeting Polymorphic Reward Genes for Carbohydrate Addiction Algorithms. J Reward Defic Syndr 1(2): 75-80.
HTML (View Full text) | PDF (Download Full text)
Commentary Open Access

Epigenetic Changes Induced by Exercise
Trevor Archer
Published on: June 19, 2015
doi: 10.17756/jrds.2015-011
Citation: Archer T. 2015. Epigenetic Changes Induced by Exercise. J Reward Defic Syndr 1(2): 71-74.
HTML (View Full text) | PDF (Download Full text)
Book Review Open Access

Two Addiction Professionals Review of “Molecular Neurobiology of Addiction Recovery: The 12 Steps Program and Fellowship”
Joan Borsten and Liz Winchell
Published on: March 25, 2015
doi: 10.17756/jrds.2015-010
Citation: Borsten J, Winchell L. 2015. Two Addiction Professionals Review of “Molecular Neurobiology of Addiction Recovery: The 12 Steps Program and Fellowship”. J Reward Defic Syndr 1(1): 69-70.
HTML (View Full text) | PDF (Download Full text)
Clinical PearlMost Viewed Open Access

Molecular Genetic Testing in Reward Deficiency Syndrome (RDS): Facts and Fiction
Kenneth Blum, Rajendra D. Badgaiyan, Gozde Agan, James Fratantonio, Thomas Simpatico, Marcelo Febo, Brett C. Haberstick, Andrew Smolen, and Mark S. Gold
Published on: March 19, 2015
doi: 10.17756/jrds.2015-009
Citation: Blum K, Badgaiyan RD, Agan G, Fratantonio J, Simpatico T, et al. 2015. Molecular Genetic Testing in Reward Deficiency Syndrome (RDS): Facts and Fiction. J Reward Defic Syndr 1(1): 65-68.
HTML (View Full text) | PDF (Download Full text) | PMC Full text
Expert OpinionMost Viewed Open Access

The Molecular Neurobiology of Twelve Steps Program & Fellowship: Connecting the Dots for Recovery
Kenneth Blum, Benjamin Thompson, Zsolt Demetrovics, John Femino, John Giordano, Marlene Oscar-Berman, Scott Teitelbaum, David E. Smith, A. Kennison Roy, Gozde Agan, James Fratantonio, Rajendra D. Badgaiyan and Mark S. Gold
Published on: March 13, 2015
doi: 10.17756/jrds.2015-008
Citation: Blum K, Thompson B, Demetrovics Z, Femino J, Giordano J, et al. 2015. The Molecular Neurobiology of Twelve Steps Program & Fellowship: Connecting the Dots for Recovery. J Reward Defic Syndr 1(1): 46-64.
HTML (View Full text) | PDF (Download Full text) | PMC Full text
Original ResearchMost Viewed Open Access

NIDA-Drug Addiction Treatment Outcome Study (DATOS) Relapse as a Function of Spirituality/Religiosity
Stephen J. Schoenthaler, Kenneth Blum, Eric R. Braverman, John Giordano, Ben Thompson, Marlene Oscar-Berman, Rajendra D. Badgaiyan, Margaret A. Madigan, Kristina Dushaj, Mona Li, Zsolt Demetrovics, Roger L. Waite and Mark S. Gold
Published on: March 10, 2015
doi: 10.17756/jrds.2015-007
Citation: Schoenthaler SJ, Blum K, Braverman ER, Giordano J, Thompson B, et al. 2015. NIDADrug Addiction Treatment Outcome Study (DATOS) Relapse as a Function of Spirituality/ Religiosity. J Reward Defic Syndr 1(1): 36-45.
HTML (View Full text) | PDF (Download Full text) | PMC Full text
Case SeriesMost Viewed Open Access

Using the Neuroadaptagen KB200z™ to Ameliorate Terrifying, Lucid Nightmares in RDS Patients: the Role of Enhanced, Brain-Reward, Functional Connectivity and Dopaminergic Homeostasis
Thomas McLaughlin, Kenneth Blum, Marlene Oscar-Berman, Marcelo Febo, Zsolt Demetrovics, Gozde Agan, James Fratantonio and Mark S. Gold
Published on: March 5, 2015
doi: 10.17756/jrds.2015-006
Citation: McLaughlin T, Blum K, Oscar-Berman M, Febo M, Demetrovics Z, et al. 2015. Using the Neuroadaptagen KB200z™ to Ameliorate Terrifying, Lucid Nightmares in RDS Patients: the Role of Enhanced, Brain-Reward, Functional Connectivity, and Dopaminergic Homeostasis. J Reward Defic Syndr 1(1): 24-35.
HTML (View Full text) | PDF (Download Full text) | PMC Full text
Hypothesis Open Access

Enhancing Brain Pregnenolone May Protect Cannabis Intoxication but Should Not Be Considered as an Anti-addiction Therapeutic: Hypothesizing Dopaminergic Blockade and Promoting Anti- Reward
Kenneth Blum, Marlene Oscar-Berman, Eric R. Braverman, Marcelo Febo, Mona Li and Mark S. Gold
Published on: February 27, 2015
doi: 10.17756/jrds.2015-005
Citation: Blum K, Oscar-Berman M, Braverman ER, Febo M, Li M, et al. 2015. Enhancing Brain Pregnenolone May Protect Cannabis Intoxication but Should Not Be Considered as an Anti-addiction Therapeutic: Hypothesizing Dopaminergic Blockade and Promoting Anti-Reward. J Reward Defic Syndr 1(1): 20-23.
HTML (View Full text) | PDF (Download Full text) | PMC Full text
Rebuttal Commentary Open Access

Do We Really Need to Continue Pharmacotherapy for Opioid Use Disorder (OUD) Indefinitely?
Rajendra D. Badgaiyan, Sampada Sinha and Kenneth Blum
Published on: February 25, 2015
doi: 10.17756/jrds.2015-004
Citation: Badgaiyan RD, Sinha S, Blum K. 2015. Do We Really Need to Continue Pharmacotherapy for Opioid Use Disorder (OUD) Indefinitely? J Reward Defic Syndr 1(1): 16-19.
HTML (View Full text) | PDF (Download Full text)